Related Experiment Video
Updated: Jun 19, 2026
10:11
Isolation and Identification of Limbal Niche Cells
Published on: October 27, 2023
New technologies in limbal epithelial stem cell transplantation
Hannah Levis1, Julie T Daniels
1Department of Ocular Biology and Therapeutics, Institute of Ophthalmology, UCL, 11-43 Bath Street, London EC1V 9EL, UK. h.levis@ucl.ac.uk
Current Opinion in Biotechnology
|October 17, 2009
Summary
The limbal epithelial stem cell (LESC) population is crucial for corneal health. Researchers are exploring alternatives to amniotic membrane (AM) for LESC transplantation to improve ocular surface repair.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Biomaterials Science
Background:
- Limbal epithelial stem cell (LESC) destruction causes vision impairment and ocular surface disorders.
- Amniotic membrane (AM) is a common but suboptimal substrate for LESC transplantation.
- Effective ocular surface repair requires ideal substrates for LESC transplantation.
Purpose of the Study:
- To review current and developing alternative substrates for limbal epithelial stem cell (LESC) transplantation.
- To evaluate the suitability of various biomaterials as replacements for amniotic membrane (AM) in ocular surface reconstruction.
Main Methods:
- Literature review of studies on alternative substrates for LESC transplantation.
- Analysis of natural and synthetic biomaterials investigated for ocular surface repair.
- Evaluation of modified amniotic membrane, cell carriers, natural substrates, and collagen scaffolds.
Main Results:
- Several alternative substrates are under investigation, including modified AM, contact lenses, gauze, fibrin, silk fibroin, and collagen-based scaffolds.
- No single alternative has yet proven to be an ideal replacement for AM.
- The development of suitable substrates for LESC transplantation is an ongoing area of research.
Conclusions:
- The search for an optimal substrate for limbal epithelial stem cell (LESC) transplantation is ongoing.
- Various biomaterials show promise but require further development for widespread clinical application.
- Advancements in biomaterials are crucial for improving outcomes in ocular surface repair.
More Related Videos
Related Concept Videos
01:19Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.